Foghorn Therapeutics Inc.FHTXNASDAQ
Loading
Year-over-year operating income growth rate
Latest
-5.92%
↓ 96% vs avg
Percentile
P38
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-3.02%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -5.92% |
| Q3 2025 | 12.31% |
| Q2 2025 | 7.93% |
| Q1 2025 | 4.55% |
| Q4 2024 | -0.64% |
| Q3 2024 | 10.44% |
| Q2 2024 | 5.54% |
| Q1 2024 | -10.75% |
| Q4 2023 | -49.04% |
| Q3 2023 | 46.71% |
| Q2 2023 | 3.80% |
| Q1 2023 | -4.49% |
| Q4 2022 | -12.83% |
| Q3 2022 | 3.18% |
| Q2 2022 | -4.98% |
| Q1 2022 | 0.99% |
| Q4 2021 | -6.93% |
| Q3 2021 | -12.90% |
| Q2 2021 | -0.57% |
| Q1 2021 | -11.31% |
| Q4 2020 | -12.39% |
| Q3 2020 | -18.98% |
| Q2 2020 | -13.23% |
| Q1 2020 | 9.63% |
| Q4 2019 | -15.92% |
| Q3 2019 | -14.92% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |